> ## Content Index
> Fetch the complete content index at: https://psychedelicmentalhealth.net/llms.txt
> Use this file to discover other available public pages before exploring further.

# Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders (Havlik, et al, 2025)
- URL: https://psychedelicmentalhealth.net/characteristics-of-ongoing-clinical-trials-of-psychogenic-substances-for-psychiatric-disorders-havlik-et-al-2025/
- Published: 2025-09-25T13:03:30.000Z
- Updated: 2025-09-25T13:03:30.000Z
- Description: "The most frequently studied substances were psilocybin (n=64; 35.4%) and ketamine (n=61; 33.7%). Trials were notably concentrated within a small number of leading academic institutions."
- Author: Michael DeMarco, PhD
- Tags: ketamine, ketamine therapy, ketamine research, psilocybin, psilocybin research, psychedelic research, clinical trials

[Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders - PubMedOngoing clinical trials of psychogenic substances for psychiatric disorders are largely concentrated at select institutions and primarily focus on psilocybin and ketamine. The majority lack clear disclosure of funding sources, highlighting a need for enhanced transparency to build trust and facilita …![](https://storage.ghost.io/c/61/a8/61a8484e-df24-47fb-903c-d012ff10c983/content/images/icon/favicon-192-111.png)PubMedJohn L Havlik![](https://storage.ghost.io/c/61/a8/61a8484e-df24-47fb-903c-d012ff10c983/content/images/thumbnail/pubmed-meta-image-v2-110.jpg)](https://pubmed.ncbi.nlm.nih.gov/40994136/)